Skip to main content Accessibility help

Accounting for Timing when Assessing Health-Related Policies

  • Karl Claxton (a1), Miqdad Asaria (a2), Collins Chansa (a3), Julian Jamison (a4), James Lomas (a5), Jessica Ochalek (a6) and Mike Paulden (a7)...

The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consumption effects avoids embedding multiple arguments in discounting policies. This helps to identify where parameters are likely to differ in particular contexts, what type of evidence would be relevant, what is currently known and how this evidence might be strengthened. The current evidence available to support the assessment of the key parameters is discussed and possible estimates and default assumptions are suggested. Reporting the results in an extensive way is recommended. This makes the assessments required explicit so the impact of alternative assumptions can be explored and analysis updated as better estimates evolve. Some projects will have effects across different countries where some or all of these parameters will differ. Therefore, the net present value of a project will be the sum of the country specific net present values rather than the sum of effects across countries discounted at some common rate.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Accounting for Timing when Assessing Health-Related Policies
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Accounting for Timing when Assessing Health-Related Policies
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Accounting for Timing when Assessing Health-Related Policies
      Available formats
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (, which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Hide All
Council of Economic Advisers. 2017. Discounting for Public Policy: Theory and Recent Evidence on the Merits of Updating the Discount Rate. Council of Economic Advisers Issue Brief.
Andrews, Martyn, Elamin, Obbey, Hall, Alastair R., Kyriakoulis, Kostas, and Sutton, Matthew. 2017. “Inference in the Presence of Redundant Moment Conditions and the Impact of Government Health Expenditure on Health Outcomes in England.” Econometric Reviews, 36(1–3): 2341.
Arrow, Kenneth J.2012. Social Choice and Individual Values (Vol. 12). New Haven: Yale University Press.
Arrow, Kenneth, Cropper, Maureen, Gollier, Christian, Groom, Ben, Heal, Geoffrey, Newell, Richard, Nordhaus, William, Pindyck, Robert, Pizer, William, and Portney, Paul. 2013. “Determining Benefits and Costs for Future Generations.” Science, 341(6144): 349350.
Arrow, Kenneth J. and Lind, Robert C.. 1970. “Uncertainty and the Evaluation of Public Investment Decisions.” American Economic Review, 60(3): 364378.
Barro, Robert J. 2009. “Rare Disasters, Asset Prices, and Welfare Costs.” American Economic Review, 99(1): 243264.
Baumstark, Luc and Gollier, Christian. 2014. “The Relevance and the Limits of the Arrow–Lind Theorem.” Journal of Natural Resources Policy Research, 6(1): 4549.
Boadway, Robin W. and Bruce, Neil. 1984. Welfare Economics. Oxford: Blackwell.
Bokhari, Farasat A. S., Gai, Yunwei, and Gottret, Pablo. 2007. “Government Health Expenditures and Health Outcomes.” Health Economics, 16(3): 257273.
Broome, John. 1978. “Trying to Value a Life.” Journal of Public Economics, 9(1): 91100.
Brouwer, Werner B. F., Culyer, Anthony J., van Exel, N. Job A., and Rutten, Frans F. H.. 2008. “Welfarism vs. Extra-welfarism.” Journal of Health Economics, 27(2): 325338.
Chapman, Clark R. 2004. “The Hazard of Near-Earth Asteroid Impacts on Earth.” Earth and Planetary Science Letters, 222(1): 115.
Claxton, Karl, Lomas, James, and Martin, Stephen. 2018. “The Impact of NHS Expenditure on Health Outcomes in England: Alternative Approaches to Identification in All-Cause and Disease Specific Models of Mortality.” Health Economics, 27(6): 10171023.
Claxton, Karl, Martin, Steve, Soares, Marta, Rice, Nigel, Spackman, Eldon, Hinde, Sebastian, Devlin, Nancy, Smith, Peter C., and Sculpher, Mark. 2015a. “Methods for the Estimation of the National Institute for Health and Care Excellence Cost-Effectiveness Threshold.” Health Technology Assessment, 19(14): 1542.
Claxton, Karl, Paulden, Mike, Gravelle, Hugh, Brouwer, Werner, and Culyer, Anthony J.. 2011. “Discounting and Decision Making in the Economic Evaluation of Health-Care Technologies.” Health Economics, 20(1): 215.
Claxton, Karl, Sculpher, Mark, Palmer, Stephen, and Culyer, Anthony J.. 2015b. “Causes for Concern: Is NICE Failing to Uphold its Responsibilities to All NHS Patients?Health Economics, 24(1): 17.
Coast, Joanna, Smith, Richard D., and Lorgelly, Paula. 2008. “Welfarism, Extra-welfarism and Capability: The Spread of Ideas in Health Economics.” Social Science and Medicine, 67(7): 11901198.
Cropper, Maureen L., Freeman, Mark C., Groom, Ben, and Pizer, William A.. 2014. “Declining Discount Rates.” American Economic Review, 104(5): 538543.
Culyer, Anthony, McCabe, Christopher, Briggs, Andrew, Claxton, Karl, Buxton, Martin, Akehurst, Ron, Sculpher, Mark, and Brazier, John. 2007. “Searching for a Threshold, Not Setting One: The Role of the National Institute for Health and Clinical Excellence.” Journal of Health Services Research and Policy, 12(1): 5658.
Dahlby, Bev. 2008. The Marginal Cost of Public Funds: Theory and Applications. Cambridge, MA: MIT Press.
Drummond, Michael F., Sculpher, Mark J., Claxton, Karl, Stoddart, Greg L., and Torrance, George W.. 2015. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
Drupp, Moritz A., Freeman, Mark C., Groom, Ben, and Nesje, Frikk. 2018. “Discounting Disentangled.” American Economic Journal: Economic Policy, 10(4): 109134.
Edney, Laura Catherine, Ali Afzali, Hossein Haji, Cheng, Terence Chai, and Karnon, Jonathan. 2018. “Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.” PharmacoEconomics, 36(2): 239252.
Emmerling, Johannes, Groom, Ben, and Wettingfeld, Tanja. 2017. “Discounting and the Representative Median Agen.” Economics Letters, 161: 7881.
Evans, David and Sezer, Haluk. 2002. “A Time Preference Measure of the Social Discount Rate for the UK.” Applied Economics, 34(15): 19251934.
Freeman, Mark C. and Groom, Ben. 2016. “How Certain are we About the Certainty-Equivalent Long Term Social Discount Rate?Journal of Environmental Economics and Management, 79: 152168.
Freeman, Mark C., Groom, Ben, Panopoulou, Ekaterini, and Pantelidis, Theologos. 2015. “Declining Discount Rates and the Fisher Effect: Inflated Past, Discounted Future?Journal of Environmental Economics and Management, 73: 3249.
Gallet, Craig A. and Doucouliagos, Hristos. 2017. “The Impact of Healthcare Spending on Health Outcomes: A Meta-Regression Analysis.” Social Science and Medicine, 179: 917.
Gold, Marthe R., Siegel, Joanna E., Russell, Louise B., and Weinstein, Milton C.. 1996. Costeffectiveness in Health and Medicine. New York: Oxford University Press.
Gollier, Christian. 2012. “Evaluation of Long-Dated Investments Under Uncertain Growth Trend, Volatility and Catastrophes.” Industrial Organisation, CESifo Working Paper.
Gollier, Christian. 2014. “Discounting and Growth.” American Economic Review, 104(5): 534537.10.1257/aer.104.5.534
Gravelle, Hugh, Brouwer, Werner, Niessen, Louis, Postma, Maarten, and Rutten, Frans. 2007. “Discounting in Economic Evaluations: Stepping Forward Towards Optimal Decision Rules.” Health Economics, 16(3): 307317.
Groom, Ben and Maddison, David Pr. 2018. “New Estimates of the Elasticity of Marginal Utility for the UK.” Environmental and Resource Economics,128; doi:10.1007/s10640-018-0242-z.
Hammitt, James K. 2000. “Valuing Mortality Risk: Theory and Practice.” Environmental Science and Technology, 34(8): 13961400.
Hammitt, James K. 2017. “Extrapolating the Value Per Statistical Life Between Populations: Theoretical Implications.” Journal of Benefit-Cost Analysis, 8(2): 215225.
Hammitt, James, K. and Robinson, Lisa A.. 2011. “The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations’.” Journal of Benefit-Cost Analysis, 2(1): 129.
Martin, Stephen, Rice, Nigel, and Smith, Peter C.. 2008. “Does Health Care Spending Improve Health Outcomes? Evidence from English Programme Budgeting Data.” Journal of Health Economics, 27(4): 826842.
Mason, Helen, Jones-Lee, Michael, and Donaldson, Cam. 2009. “Modelling the Monetary Value of a QALY: A New Approach Based on UK Data.” Health Economics, 18(8): 933950.
Masterman, Clayton J. and Viscusi, W. Kip. 2018. “The Income Elasticity of Global Values of a Statistical Life: Stated Preference Evidence.” Journal of Benefit-Cost Analysis, 9(3): 407434.
Meltzer, David. 2013. “Future Costs in Medical Cost-Effectiveness Analysis.” In Jones, Andrew (Ed.), The Elgar Companion to Health Economics (pp. 481–489). Cheltenham: Edward Elgar Publishing Ltd.
Nakamura, Ryota, Lomas, James Richard Scott, Claxton, Karl Philip, Bokhari, Farasat, Serra, Rodrigo Antonio Moreno, and Suhrcke, Marc Eckart. 2016. Centre for Health Economics Research Paper, 128, University of York.
Neumann, Peter J., Sanders, Gillian D., Russell, Louise B., Siegel, Joanna E., and Ganiats, Theodore G.. 2016. Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press.
Nord, Erik. 2011. “Discounting Future Health Benefits: the Poverty of Consistency Arguments.” Health Economics, 20(1): 1626.
Nordhaus, William D. 2007. “A Review of the Stern Review on the Economics of Climate Change.” Journal of Economic Literature, 45(3): 686702.
Ochalek, Jessica, Lomas, James, and Claxton, Karl. 2015. Cost Per DALY Averted Thresholds for low- and Middle-income Countries: Evidence From Cross Country Data. Centre for Health Economics Research Paper, 128, University of York.
Ochalek, Jessica, Lomas, James, and Claxton, Karl. 2018. “Estimating Health Opportunity Costs in Low-income and Middle-income Countries: A Novel Approach and Evidence From Cross-country Data.” BMJ Global Health, 3(6): e000964.
Paulden, Mike and Claxton, Karl. 2012. “Budget Allocation and the Revealed Social Rate of Time Preference for Health.” Health Economics, 21(5): 612618.
Paulden, Mile, Galvanni, Valentina, Chakraborty, Samprita, Kudinga, Beniot, and McCabe, Christopher. 2016. Discounting and the Evaluation of Health Care Programs. Canadian Agency for Drugs and Technologies in Health. Available at (accessed 2nd December 2018).
Paulden, Mike, O’Mahony, James, and McCabe, Christopher. 2017. “Determinants of Change in the Cost-effectiveness Threshold.” Medical Decision Making, 37(2): 264276.
Phelps, Charles E. and Mushlin, Alvin I.. 1991. “On the (Near) Equivalence of Cost-effectiveness and Cost-benefit Analyses.” International Journal of Technology Assessment in Health Care, 7(1): 1221.
Pinto-Prades, Jose Luis, Loomes, Graham, and Brey, Raul. 2009. “Trying to Estimate a Monetary Value for the QALY.” Journal of Health Economics, 28(3): 553562.
Robinson, Lisa A. and Hammitt, James K.. 2018. “Valuing Nonfatal Risk Reductions in Global Benefit-Cost Analysis.” In Guidelines for Benefit-Cost Analysis Project, Guidelines for Benefit-Cost Analysis Project Working Paper No. 2.
Robinson, Lisa A., Hammitt, James K., Chang, Angela Y., and Resch, Stephen. 2016. “Understanding and Improving the One and Three Times GDP Per Capita Cost-Effectiveness Thresholds.” Health Policy and Planning, 32(1): 141145.
Robinson, Lisa A., Hammitt, James K., and O’Keeffe, Lucy. 2019. “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.” Journal of Benefit-Cost Analysis, 9(4): forthcoming.
Ruggeri, Giuseppe. 1999. “The Marginal Cost of Public Funds in Closed and Small Open Economies.” Fiscal Studies, 20(1): 4160.
Ryen, Linda and Svensson, Mikael. 2015. “The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.” Health Economics, 24(10): 12891301.
Sen, Amartya. 1979. “Personal Utilities and Public Judgements: Or What’s Wrong with Welfare Economics.” The Economic Journal, 89: 537558.
Stern, Nicholas. 2007. The Economics of Climate Change: the Stern Review. Cambridge, UK: Cambridge University Press.
Stern, Nicholas. 2008. “The Economics of Climate Change.” American Economic Review, 98(2): 137.
Stinnett, Aaron A. and Mullahy, John. 1998. “Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis.” Medical Decision Making, 18(2 suppl): S68S80.
Thokala, Praveen, Ochalek, Jessica, Leech, Ashley A., and Tong, Thaison. 2018. “Cost-effectiveness Thresholds: The Past, the Present and the Fiuture.” PharmacoEconomics, 36(5): 509522.
Vallejo-Torres, Laura, García-Lorenzo, Borja, Castilla, Iván, Valcárcel-Nazco, Cristina, García-Pérez, Lidia, Linertová, Renata, Polentinos-Castro, Elena, and Serrano-Aguilar, Pedro. 2016. “On the Estimation of the Cost-effectiveness Threshold: Why, What, How?Value in Health, 19(5): 558566.
Viscusi, W. Kip and Masterman, Clayton. 2017. “Income Elasticity and the Global Value of a Statistical Life.” Journal of Benefit-Cost Analysis, 8(2): 226250.
Woods, Beth, Revill, Paul, Sculpher, Mark, and Claxton, Karl. 2016. “Country-level Cost-effectiveness Thresholds: Initial Estimates and the Need for Further Research.” Value in Health, 19(8): 929935.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Benefit-Cost Analysis
  • ISSN: 2194-5888
  • EISSN: 2152-2812
  • URL: /core/journals/journal-of-benefit-cost-analysis
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed